-
Most Recent
Search Results
240 results for MER
The Bigger Story Behind March’s Market Selloff
In today’s Market 360, I want to show you why the market’s recent March Madness may prove temporary, why investors are already starting to look…
AIG’s House of Falling Cards
It’s tough to watch grown men cry, especially when they are unemotional, conservative bankers. But before we all start to feel bad for them, we…
Short-Squeeze Stocks: Top 10 Stocks With High Short Interest This Week
We’re seeing loads of activity from retail traders that has us looking in on short-squeeze stocks investors will want to know about.
3 China ETFs Worth Betting On
China ETFs have taken it on the chin lately, and it’s hard to know when it will get better. Nonetheless, here are three ETFs worth…
A Financial-Led Rally?
Everyone is speculating about financial stocks and if we’ve seen a “dead-cat bounce” or a true bottom. Read on to get the truth about the…
New on Netflix in December 2016: 34 New Netflix Movies
What movies are new on Netflix in December? Here are 34 film and TV titles that you should watch on the online streaming site next…
Your 48-Hour Guide to Surviving Chaos: Buy This, Sell That
What happens between now and August 1 is anybody’s guess. The headlines have changed before, and they could very well change again come Friday, tomorrow,…
Inovio Stock Shows Plenty of Promise Ahead
The clinical results from Inovo’s INO-4700 validate the upside potential in INO stock.
3 Actively Managed ETFs Worth Your Money
Actively managed ETFs are a relatively niche product and go against the growing trend of passive, index-based fund investing. Still, a few managers are worth…
The Case for Buying Inovio Will Come Down to the Test Results
INO stock is up over 300% in 2020. But investors are going all in on the company’s Covid-19 vaccine candidate, and that’s still a gamble.
History and Competition Suggest Caution Toward Inovio Stock
INO stock has rallied more than 700% so far this year. But the company needs to succeed where it has failed in the past and…
Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Tuesday Morning
Tuesday’s here and early risers can get up to speed with a look at the winners and losers of pre-market movers for today.
Will Goldman Sachs Be Next?
Do we dare say it? It has become a sport this week to predict the shoe that will drop next. Why not join the fray with…
Shutdown-Proof Stocks to Watch – and Where to Find More Like Them
To use an overused phrase, we’ve entered a “stock-picker’s market.” That means focusing on specific stocks with attractive growth characteristics, rather than relying on one…
GILD Stock Looks Poised for a Serious Coronavirus Bump
There’s a good chance that Gilead’s drug will become the coronavirus vaccine, making Gilead stock attractive.
The 60/40 Portfolio Was Built for a World That No Longer Exists
Resource sovereignty is reshaping markets, inflation, and investing – favoring energy, minerals, and real assets over globalized tech.
Gilead Sciences News: GILD Stock Surges 3% on Coronavirus Drug Hopes
Gilead Sciences (GILD) news for Monday concerning a drug that may be able to treat the new coronavirus from China have GILD stock up.
Inovio Pharmaceuticals Inc (INO) Spikes on HIV Vaccine Trial Results
Inovia Pharmaceuticals Inc (INO) jumped more than 30% its HIV vaccine showed some of the highest overall rates of immune response ever.
Selling Calls: A Closer Look at Shorting Calls
Learn how a short call gives you the ability to profit if the market falls, remains flat or even rises.
3 – 10 of 240 results
